2m 2m 2m 2m 2m 2m 2m
Perrigo (PRGO)
NYSE
$10.55+$0.09 (+0.86%)
Price as of Jun 03, 2026 5:34 PM EDT- $1.6BMarket Cap
- -57.19%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Perrigo (PRGO)
$10.55+$0.09 (+0.86%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.3B -2.75% | 4.4B -6.06% | 4.7B +4.58% | 4.5B +7.56% | |
Cost of Revenue | 2.8B -2.55% | 2.8B -4.86% | 3.0B -0.70% | 3.0B +10.05% | |
Gross Profit | 1.5B -3.12% | 1.5B -8.19% | 1.7B +15.46% | 1.5B +2.77% | |
Sales and Marketing Expense | 526.5M -3.68% | 546.6M -14.83% | 641.8M +9.75% | 584.8M +9.02% | |
Research and Development Expense | -188.8M -10.18% | -210.2M -9.79% | -233.0M -1.31% | -236.1M +9.81% | |
Depreciation and Amortization Expense | 337.5M +3.56% | 325.9M -9.35% | 359.5M +6.17% | 338.6M +8.46% | |
Total Operating Expenses | 2.6B +83.01% | 1.4B -6.46% | 1.5B +11.04% | 1.4B +36.86% | |
Operating Profit | -1.1B -1,093.98% | 112.9M -25.67% | 151.9M +92.52% | 78.9M -80.77% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -162.5M -13.47% | -187.8M +8.06% | -173.8M +11.41% | -156.0M +24.80% | |
Interest Income and Expense and Net | -162.5M -13.47% | -187.8M +8.06% | -173.8M +11.41% | -156.0M +24.80% | |
Total Nonoperating Income and Expense | -13.2M -1,566.67% | 900,000 -91.35% | 10.4M +119.59% | -53.1M +98.88% | |
Income before Taxes | -1.3B +1,508.30% | -80.7M +872.29% | -8.3M -94.03% | -139.1M -153.77% | |
Income Taxes | 104.4M +30.50% | 80.0M +2,151.28% | -3.9M -52.44% | -8.2M -102.10% | |
Extraordinary Items | 1.4B +1,433.30% | 88.9M -1.22% | 90.0M N/A | 0 -100.00% | |
Net Income | -1.4B +729.69% | -171.8M +1,252.76% | -12.7M -90.97% | -140.6M +104.06% | |
Net Income from Continuing Operations Applicable to Common | -1.4B +772.62% | -160.7M +3,552.27% | -4.4M -96.64% | -130.9M 0.00% | |
Basic EPS and Net Income | -10.29 +723.20% | -1.25 +1,288.89% | -0.09 -91.35% | -1.04 +100.00% | |
Diluted EPS and Net Income | -10.29 +723.20% | -1.25 +1,288.89% | -0.09 -91.35% | -1.04 +100.00% | |
Basic Weighted Average Shares | 138.5M +0.80% | 137.4M +1.55% | 135.3M +0.59% | 134.5M +0.67% | |
Diluted Weighted Average Shares | 138.5M +0.80% | 137.4M +1.55% | 135.3M +0.59% | 134.5M +0.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 531.6M -4.87% | 558.8M -25.62% | 751.3M +25.07% | 600.7M -67.79% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 531.6M -4.87% | 558.8M -25.62% | 751.3M +25.07% | 600.7M -67.79% | |
Total Current Assets | 2.8B +12.71% | 2.5B -12.39% | 2.8B +4.15% | 2.7B -29.53% | |
Accumulated Depreciation | 1.3B +10.33% | 1.1B +6.45% | 1.1B +8.32% | 990.0M +8.60% | |
Property and Plant and Equipment and Net | 898.7M -2.08% | 917.8M +0.15% | 916.4M -1.07% | 926.3M +7.20% | |
Total Long-Term Assets | 5.7B -19.93% | 7.2B -10.16% | 8.0B -3.87% | 8.3B +26.37% | |
Total Assets | 8.5B -11.53% | 9.6B -10.74% | 10.8B -1.89% | 11.0B +5.67% | |
Income Taxes Payable | 189.7M -14.01% | 220.6M -27.53% | 304.4M -20.44% | 382.6M +49.57% | |
Total Short-Term Debt | 36.6M +0.55% | 36.4M -91.74% | 440.6M +1,117.13% | 36.2M -94.00% | |
Total Current Liabilities | 1.0B -3.00% | 1.0B -34.17% | 1.6B +42.45% | 1.1B -29.87% | |
Total Long-Term Debt | 3.6B +0.61% | 3.6B -1.41% | 3.6B -10.75% | 4.1B +39.55% | |
Total Long-Term Liabilities | 4.6B +7.07% | 4.3B -3.83% | 4.5B -11.99% | 5.1B +37.32% | |
Total Liabilities | 5.6B +5.09% | 5.3B -11.80% | 6.0B -2.17% | 6.2B +17.09% | |
Retained Earnings | -3.7B +63.29% | -2.3B +8.26% | -2.1B +0.61% | -2.1B +7.30% | |
Total Stockholders Equity | 2.9B -32.04% | 4.3B -9.41% | 4.8B -1.53% | 4.8B -6.01% | |
Total Shares Outstanding | 137.6M +0.81% | 136.5M +0.74% | 135.5M +0.59% | 134.7M +0.67% | |
Cash Flow | |||||
Cash from Operating Activities | 238.5M -34.28% | 362.9M -10.51% | 405.5M +31.96% | 307.3M +96.61% | |
Capital Expenditures | 93.4M -21.05% | 118.3M +16.32% | 101.7M +5.50% | 96.4M -36.62% | |
Cash from Investing Activities | -75.4M -195.69% | 78.8M +201.68% | -77.5M -96.04% | -2.0B -253.52% | |
Dividends Paid | 159.3M +4.46% | 152.5M +1.87% | 149.7M +5.13% | 142.4M +9.88% | |
Cash from Financing Activities | -220.5M -63.91% | -611.0M +226.39% | -187.2M -144.40% | 421.6M +335.93% | |
Financials Ratio | |||||
Gross Margin | 35.14% -0.38% | 35.27% -2.27% | 36.09% +10.40% | 32.69% -4.46% | |
Operating Margin | -26.39% -1,122.10% | 2.58% -20.88% | 3.26% +84.08% | 1.77% -82.13% | |
Return on Assets | -15.68% +833.47% | -1.68% +1,342.96% | -0.12% -91.12% | -1.31% +108.56% | |
Return on Equity | -39.29% +939.24% | -3.78% +1,330.61% | -0.26% -90.61% | -2.81% +120.67% | |
Revenue Growth | -2.75% -54.62% | -6.06% -232.27% | 4.58% -39.39% | 7.56% +141.40% | |
Current Ratio | 2.76 +16.20% | 2.38 +33.09% | 1.79 -26.88% | 2.44 +0.48% | |
Cash Ratio | 0.52 -1.92% | 0.54 +12.99% | 0.47 -12.20% | 0.54 -54.07% | |
Debt-to-Equity Ratio | 1.24 +48.05% | 0.84 -1.95% | 0.85 +0.73% | 0.85 +24.10% | |
Debt-to-Assets Ratio | 0.43 +13.73% | 0.38 -0.48% | 0.38 +1.10% | 0.37 +10.36% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow